NCT02729584

Brief Summary

The study aims at evaluating in normal weight and obese subjects those factors such as taste sensitivity and circulating endocannabinoids in influencing dietary choice and thereby lipid and energy metabolism in order to design personalized nutritional strategies.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2013

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 23, 2016

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 6, 2016

Completed
Last Updated

April 6, 2016

Status Verified

March 1, 2016

Enrollment Period

2.2 years

First QC Date

March 23, 2016

Last Update Submit

March 31, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Endocannabinoid plasma levels

    1 year

Study Arms (2)

Normal weight

Obese

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

White Caucasians

You may qualify if:

  • Body Mass Index (BMI), range for normal weight subjects 17.5-24.95, for obese subjects 29.6-52.20
  • No intake of nutritional supplements for at least six months before the trial

You may not qualify if:

  • major diseases (diabetes, kidney disease, etc.),
  • pregnancy or lactation;
  • food allergies;
  • the use of medications that interfere with taste or smell (e.g., steroids, antihistamines, certain antidepressants).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 23, 2016

First Posted

April 6, 2016

Study Start

April 1, 2013

Primary Completion

June 1, 2015

Study Completion

September 1, 2015

Last Updated

April 6, 2016

Record last verified: 2016-03

Data Sharing

IPD Sharing
Will not share